Ahmed M. Morshed
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Ahmed M. Morshed has a total of 106 co-authors. Here are the top co-authors by number of shared publications:
- Tara Marie Mastracci
Division of Surgery and Interventional Sciences, University College London, UK (T.M.M.).
3 shared publications Ahmed Elbasty
2 shared publicationsAhmed Helal
2 shared publications- Arindam Chaudhuri
Bedfordshire - Milton Keynes Vascular Centre, Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK
2 shared publications Chris Miller
2 shared publicationsClaire Ryan
2 shared publications
Latest Publications
- 12 November 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (5) , e122
The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study: Early experience with the GORE TAG thoracic branch endoprosthesis
- 12 November 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (5) , e122
The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study: Early experience with the GORE TAG thoracic branch endoprosthesis
- 14 October 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 134, 852-865
Endovascular Iliac Stenting Versus Open Aortobifemoral Bypass for Aortoiliac Occlusive Disease: A Retrospective Multicentre Cohort Study
- 14 October 2026
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 134, 852-865
Endovascular Iliac Stenting Versus Open Aortobifemoral Bypass for Aortoiliac Occlusive Disease: A Retrospective Multicentre Cohort Study
- 6 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (5) , 1077-1089.e6
The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study (UK-BEAT): Early experience with the GORE TAG thoracic branch endoprosthesis
- 6 July 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 84 (5) , 1077-1089.e6
The United Kingdom Branch Endoprosthesis for Aortic arch Treatment study (UK-BEAT): Early experience with the GORE TAG thoracic branch endoprosthesis
- 11 May 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Mid-Term Outcomes of Percutaneous Deep Venous Arterialization Using the LimFlow System
Background & objectives: Chronic limb-threatening ischaemia (CLTI) not amenable to conventional revascularization options (no-option CLTI) is associated with high rates of major amputation and mortality. Promising results were reported following percutaneous deep venous arterialization (pDVA) using the LimFlow system. This study reports mid-to-long-term clinical and patency outcomes of pDVA in real-life single-centre settings. Design: Retrospective, single-arm cohort study. Methods: The study included patients with no-option CLTI (Rutherford classes 5 and 6) who underwent pDVA using the LimFlow between January 2020 and June 2024. Patients were designated “no-option” by a multidisciplinary team after exhausting conventional revascularization options. Primary outcome was amputation-free survival (AFS). Secondary outcomes included technical success, limb salvage (LS), primary and secondary patency (PP/SP), freedom from reintervention (FFR) and wound healing rates. Results: Thirty-four patients (median age of 67 years; 79.4% diabetic) were included, with a median follow-up of 21 months (4–62 months). Technical success was 100%. At 24 months, AFS was 72% and LS was 88.6%. Full wound healing was achieved in 66% of patients, with a median time of 262 days from the index procedure. Kaplan-Meier analysis showed 24-month PP and SP rates of 46.3% and 76%, respectively. Freedom from reintervention was 58% at 24 months. Four major amputations (11.7%) were required. Conclusion: Percutaneous deep venous arterialization using the LimFlow system provides acceptable mid-term outcomes. Satisfactory AFS, LS, PP, SP and wound healing rates were achieved in these no-option CLTI options. Strict post-procedure surveillance and reintervention protocols are essential to maintain satisfactory outcomes. Clinical Impact: The LimFlow system introduces a novel option for patients with no revascularization alternatives. It enables limb salvage in severe CLTI cases previously destined for amputation. By creating arterial flow through the venous system, it redefines vascular intervention strategies. Clinicians gain a new tool for “no-option” patients, expanding treatment eligibility. This may reduce major amputation rates and improve quality of life. The approach requires new technical skills and multidisciplinary collaboration. It shifts practice toward advanced endovascular innovation rather than palliative care. Patient selection and procedural expertise become critical for success. The study highlights the feasibility and safety of transcatheter arterialization. Overall, it represents a paradigm shift in managing advanced peripheral artery disease.
- 11 May 2026
- Published by SAGE Publications in Journal of Endovascular Therapy
Mid-Term Outcomes of Percutaneous Deep Venous Arterialization Using the LimFlow System
Background & objectives: Chronic limb-threatening ischaemia (CLTI) not amenable to conventional revascularization options (no-option CLTI) is associated with high rates of major amputation and mortality. Promising results were reported following percutaneous deep venous arterialization (pDVA) using the LimFlow system. This study reports mid-to-long-term clinical and patency outcomes of pDVA in real-life single-centre settings. Design: Retrospective, single-arm cohort study. Methods: The study included patients with no-option CLTI (Rutherford classes 5 and 6) who underwent pDVA using the LimFlow between January 2020 and June 2024. Patients were designated “no-option” by a multidisciplinary team after exhausting conventional revascularization options. Primary outcome was amputation-free survival (AFS). Secondary outcomes included technical success, limb salvage (LS), primary and secondary patency (PP/SP), freedom from reintervention (FFR) and wound healing rates. Results: Thirty-four patients (median age of 67 years; 79.4% diabetic) were included, with a median follow-up of 21 months (4–62 months). Technical success was 100%. At 24 months, AFS was 72% and LS was 88.6%. Full wound healing was achieved in 66% of patients, with a median time of 262 days from the index procedure. Kaplan-Meier analysis showed 24-month PP and SP rates of 46.3% and 76%, respectively. Freedom from reintervention was 58% at 24 months. Four major amputations (11.7%) were required. Conclusion: Percutaneous deep venous arterialization using the LimFlow system provides acceptable mid-term outcomes. Satisfactory AFS, LS, PP, SP and wound healing rates were achieved in these no-option CLTI options. Strict post-procedure surveillance and reintervention protocols are essential to maintain satisfactory outcomes. Clinical Impact: The LimFlow system introduces a novel option for patients with no revascularization alternatives. It enables limb salvage in severe CLTI cases previously destined for amputation. By creating arterial flow through the venous system, it redefines vascular intervention strategies. Clinicians gain a new tool for “no-option” patients, expanding treatment eligibility. This may reduce major amputation rates and improve quality of life. The approach requires new technical skills and multidisciplinary collaboration. It shifts practice toward advanced endovascular innovation rather than palliative care. Patient selection and procedural expertise become critical for success. The study highlights the feasibility and safety of transcatheter arterialization. Overall, it represents a paradigm shift in managing advanced peripheral artery disease.
- Open Access
- 26 February 2026
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 12 (3) , 102191
Stewart Treves syndrome as a catastrophic sequela of chronic lymphedema: Clinical spectrum, management challenges, and outcomes
- 26 February 2026
- Published by Elsevier in Journal of Vascular Surgery Cases, Innovations and Techniques
- Vol. 12 (3) , 102191
Open AccessStewart Treves syndrome as a catastrophic sequela of chronic lymphedema: Clinical spectrum, management challenges, and outcomes
- Open Access
- 21 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (3) , 523-530
Outcomes following Revascularisation for Acute Lower Limb Ischaemia Using Contemporary Endovascular, Hybrid, or Open Surgical Techniques in a Multicentre, Retrospective Cohort: The Acute Lower Limb Ischaemia Vascular Outcomes Evaluation (ALIVE) Registry
- 21 January 2026
- Published by Elsevier in European Journal of Vascular and Endovascular Surgery
- Vol. 72 (3) , 523-530
Open AccessOutcomes following Revascularisation for Acute Lower Limb Ischaemia Using Contemporary Endovascular, Hybrid, or Open Surgical Techniques in a Multicentre, Retrospective Cohort: The Acute Lower Limb Ischaemia Vascular Outcomes Evaluation (ALIVE) Registry
- Open Access
- 10 October 2024
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 13 (1) , 101987
Hybrid approach of massive lipolymphedema of the thigh: A novel surgical technique
- 10 October 2024
- Published by Elsevier in Journal of Vascular Surgery: Venous and Lymphatic Disorders
- Vol. 13 (1) , 101987
Open AccessHybrid approach of massive lipolymphedema of the thigh: A novel surgical technique
- 31 July 2023
- Published by SAGE Publications in Vascular
- Vol. 32 (5) , 983-990
Outcome of different endovascular modalities to treat common iliac artery aneurysms, single center study
Introduction: Iliac aneurysms occur in 10% of patients with abdominal aortic aneurysms (AAA). There are three different endovascular approaches to their treatment in the context of infrarenal Endovascular Aortic Aneurysm Repair (EVAR): occlusion by coiling the internal iliac, incorporation using an iliac branch device, and delaying repair using a bell bottom limb. We sought to determine outcomes associated with these three strategies in our practice. Methodology: The study was a combined prospective cohort study with a retrospective arm: prospective patient recruitment was done for 1 year from September 2019 and ended by September 2020, and retrospective data was collected from 2017 to 2019. Demographic, procedural, and imaging data was collected. SPSS was used to analyze data as patients were classified by limbs in four groups: iliac branched, bell bottom, coil and cover technique, and standard treated limbs. Results: There were 65 male and 4 female patients included in this study incorporating 137 limbs with a mean age of 78 years (SD ± 8 years). Two patients died after discharge (at 3 and 21 months postoperatively, without hospital admission) and five patients were lost to long-term follow-up. Three patients had operations that deviated from the plan: one was an IBD converted to bell bottom, one was an IBD that was converted to coil and cover, and one was a bell bottom that did not seal. Follow-up revealed late type IB endoleak in three bell bottom limbs and one limb treated with coil and cover. Common iliac occlusion occurred in one IBD, three bell bottom limbs, and two limbs treated with coil/cover technique. There were four additional ischemic events (buttock claudication in three and intestinal ischemia in one): all ischemic events occurred in the coil and cover group ( p = .001). Conclusions: Given the small population size examined in this study, there is no statistical difference between treatment groups; however, there was a trend toward bell bottom technique being associated with higher incidence of type IB endoleak. Coil and cover technique was associated with decreased IB endoleak; however, Buttock claudication and intestinal ischemia occurred more significantly in this group. Using IBD may be the best strategy to improve short- and long-term outcomes in patients with iliac aneurysms.
- 31 July 2023
- Published by SAGE Publications in Vascular
- Vol. 32 (5) , 983-990
Outcome of different endovascular modalities to treat common iliac artery aneurysms, single center study
Introduction: Iliac aneurysms occur in 10% of patients with abdominal aortic aneurysms (AAA). There are three different endovascular approaches to their treatment in the context of infrarenal Endovascular Aortic Aneurysm Repair (EVAR): occlusion by coiling the internal iliac, incorporation using an iliac branch device, and delaying repair using a bell bottom limb. We sought to determine outcomes associated with these three strategies in our practice. Methodology: The study was a combined prospective cohort study with a retrospective arm: prospective patient recruitment was done for 1 year from September 2019 and ended by September 2020, and retrospective data was collected from 2017 to 2019. Demographic, procedural, and imaging data was collected. SPSS was used to analyze data as patients were classified by limbs in four groups: iliac branched, bell bottom, coil and cover technique, and standard treated limbs. Results: There were 65 male and 4 female patients included in this study incorporating 137 limbs with a mean age of 78 years (SD ± 8 years). Two patients died after discharge (at 3 and 21 months postoperatively, without hospital admission) and five patients were lost to long-term follow-up. Three patients had operations that deviated from the plan: one was an IBD converted to bell bottom, one was an IBD that was converted to coil and cover, and one was a bell bottom that did not seal. Follow-up revealed late type IB endoleak in three bell bottom limbs and one limb treated with coil and cover. Common iliac occlusion occurred in one IBD, three bell bottom limbs, and two limbs treated with coil/cover technique. There were four additional ischemic events (buttock claudication in three and intestinal ischemia in one): all ischemic events occurred in the coil and cover group ( p = .001). Conclusions: Given the small population size examined in this study, there is no statistical difference between treatment groups; however, there was a trend toward bell bottom technique being associated with higher incidence of type IB endoleak. Coil and cover technique was associated with decreased IB endoleak; however, Buttock claudication and intestinal ischemia occurred more significantly in this group. Using IBD may be the best strategy to improve short- and long-term outcomes in patients with iliac aneurysms.